Format

Send to

Choose Destination
J Med Chem. 2008 Jun 26;51(12):3480-6. doi: 10.1021/jm800030e.

CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.

Author information

1
Lek Pharmaceuticals d d, Verovskova 57, SI-1000 Ljubljana, Slovenia. barbara.podobnik@sadoz.com

Abstract

A novel cytochrome P450, CYP53A15, was identified in the pathogenic filamentous ascomycete Cochliobolus lunatus. The protein, classified into the CYP53 family, was capable of para hydroxylation of benzoate. Benzoate is a key intermediate in the metabolism of aromatic compounds in fungi and yet basically toxic to the organism. To guide functional analyses, protein structure was predicted by homology modeling. Since many naturally occurring antifungal phenolic compounds are structurally similar to CYP53A15 substrates, we tested their putative binding into the active site of CYP53A15. Some of these compounds inhibited CYP53A15. Increased antifungal activity was observed when tested in the presence of benzoate. Some results suggest that CYP53A15 O-demethylation activity is important in detoxification of other antifungal substances. With the design of potent inhibitors, CYP53 enzymes could serve as alternative antifungal drug targets.

PMID:
18505250
DOI:
10.1021/jm800030e
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center